Infectious Diseases News and Research

RSS

Structure and function of the first FDA-approved treatment for Ebola virus discovered

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).

30 Jan 2023

Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

30 Jan 2023

New model shows how infectious diseases evolve in space and time

A new disease model that can account for contact patterns between age groups shows how infectious diseases evolve in space and time and how to predict future case numbers across a region.

30 Jan 2023

NCI awards $3.5 million grant to eliminate cervical cancer among women with HIV in low-resource countries

Weill Cornell Medicine, Moffitt Cancer Center in Tampa, Fla., and the University of North Carolina have received a $3.5 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to improve screening and preventative treatment of cervical cancer for women living with HIV in low-resource countries.

30 Jan 2023

Study evaluates post-acute sequelae of COVID-19 in US university

Researchers examined the prevalence and predictors of long coronavirus disease (COVID) in a sample representing a Washington, DC University staff in the United States of America (USA).

30 Jan 2023

Importance of Global Pandemic Predictions for Future Outbreaks; How prepared are we?

In this interview, we speak to Ron Gutman, Co-CEO and Co-Founder of Intrivo, about the importance of global pandemic predictions for future outbreaks.

30 Jan 2023

Children’s immune systems do not develop ‘adaptive’ memory to protect against second time SARS-CoV-2 infection

Children have largely avoided severe COVID-19 symptoms because they have a strong initial 'innate' immune reaction that quickly defeats the virus.

26 Jan 2023

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

According to the World Health Organization, each year there are an estimated 1 billion cases of influenza, between 3-5 million severe cases and up to 650,000 influenza-related respiratory deaths globally.

25 Jan 2023

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.

25 Jan 2023

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Researchers described the coronavirus disease 2019 (COVID-19) prevention network (CoVPN) and its contribution to clinical efficacy evaluations of COVID-19 vaccines in phase 3 trials.

25 Jan 2023

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

The potential "tripledemic" of influenza, SARS-CoV-2 and RSV (respiratory syncytial virus) infection continues to be a concern.

25 Jan 2023

The efficacy of clarithromycin versus levofoxacin-based regimens for H.pylori treatment in naïve patients after the COVID-19 pandemic misuse of antibiotics

Researchers explored the eradication rates of Helicobacter pylori utilizing levofloxacin and clarithromycin-based regimens in patients with prior COVID-19 therapy.

25 Jan 2023

Promoting the One Health approach could greatly improve human-animal health and environmental integrity

Researchers pursued contemporary evidence of how One Health approaches could improve health security at a global scale against unprecedented health hazards, such as the one posed by the coronavirus disease 2019 (COVID-19) pandemic.

24 Jan 2023

High adherence to procalcitonin-guided antibiotic prescribing guideline may reduce antibiotic use in hospitals

A study published in the journal BMC Infectious Diseases claims that high adherence to procalcitonin-guided antibiotic prescribing guidelines is necessary to reduce antibiotic use in patients with suspected lower respiratory tract infections.

23 Jan 2023

New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

23 Jan 2023

Genetic disorder that causes immunodeficiency and susceptibility to opportunistic infections discovered

An international consortium co-led by Vanderbilt University Medical Center immunogeneticist Rubén Martínez-Barricarte, PhD, has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia.

23 Jan 2023

Infectious Diseases News and Research

Structure and function of the first FDA-approved treatment for Ebola virus discovered

Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

New model shows how infectious diseases evolve in space and time

NCI awards $3.5 million grant to eliminate cervical cancer among women with HIV in low-resource countries

Study evaluates post-acute sequelae of COVID-19 in US university

Importance of Global Pandemic Predictions for Future Outbreaks; How prepared are we?

Children’s immune systems do not develop ‘adaptive’ memory to protect against second time SARS-CoV-2 infection

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Breathing and tilting motions of influenza glycoproteins could be exploited to better defend against flu

The efficacy of clarithromycin versus levofoxacin-based regimens for H.pylori treatment in naïve patients after the COVID-19 pandemic misuse of antibiotics

Promoting the One Health approach could greatly improve human-animal health and environmental integrity

High adherence to procalcitonin-guided antibiotic prescribing guideline may reduce antibiotic use in hospitals

New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

Genetic disorder that causes immunodeficiency and susceptibility to opportunistic infections discovered

Study reveals the mechanism through which Sirtuin 7 protein suppresses thermogenesis in mice

People with hybrid immunity are the most protected against severe COVID-19 and reinfection

Buprenorphine-involved overdose deaths did not increase after implementation of prescribing flexibilities

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News